4.6 Article

Drug-gut microbiota metabolic interactions: the case of UniPR1331, selective antagonist of the Eph-ephrin system, in mice

出版社

ELSEVIER
DOI: 10.1016/j.jpba.2019.113067

关键词

Eph-ephrin system; UniPR1331; High performance liquid chromatography (HPLC); High-resolution mass spectrometry (HR-MS); Drug-gut microbiota interactions; Faecal fermentation assay

资金

  1. Centro Interdipartimentale Misure (CIM) G. Casnati of the University of Parma

向作者/读者索取更多资源

The interest on the role of gut microbiota in the biotransformation of drugs and xenobiotics has grown over the last decades and a deeper understanding of the mutual interactions is expected to help future improvements in the fields of drug development, toxicological risk assessment and precision medicine. In this paper, a microbiome drug metabolism case is presented, involving a lipophilic small molecule,N-(3 beta-hydroxy-Delta(5)-cholen-24-oyl)-L-tryptophan, UniPR1331, active as antagonist of the Eph ephrin system and effective in vivo in a murine orthotopic model of glioblastoma multiforme (GBM). Following the administration of a single 30 mg/l

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据